CD28 and colorectal carcinoma: Flow cytometry showed that ZQFZ treatment increased the number of CD3e+CD28+ cells and CD3e-NK1.1+ cells in the peripheral blood of ApcMin/+ mice, indicating that the anti-CRC effect of ZQFZ may be achieved by increasing the number of immune cells.